Therapeutic effect of a novel long-actingGLP-1/GIP/Glucagon triple agonist (HM15211) in CDHFD-induced NASH and fibrosis mice

被引：0
|
作者：
Choi, J. [1 ]
Jo, H. [1 ]
Kim, J. [1 ]
Kwon, H. [1 ]
Lee, J. [1 ]
Bae, S. [1 ]
Kim, D. [1 ]
Lee, S. [1 ]
Choi, I. [1 ]
机构：
[1] Hanmi Pharm Co Ltd, Hwaseong Si, Gyeonggi Do, South Korea
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
127
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [31] Novel long-acting GLP-1/GIP/Glucagon triple agonist (HM15211) exhibits anti-inflammatory and - fibrotic effects in AMLN/TAA induced liver inflammation and fibrosis mice
    Jo, H.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S417 - S417
  • [32] ANTI -INFLAMMATION AND ANTI-FIBROSIS EFFECTS OF A NOVEL LONG-ACTING GLUCAGON/GIP/GLP-1 TRIPLE AGONIST TRIPLE AGONIST (HM15211) IN AMLN/TAA INDUCED MOUSE MODEL OF LIVER INFLAMMATION AND FIBROSIS
    Lee, Jong Suk
    Jo, Hyo Sang
    Kim, Jung Kuk
    Lee, Seon Myeong
    Park, Eun Jin
    Bae, Sung Min
    Kim, Dae Jin
    Kim, Young Hoon
    Choi, In Young
    HEPATOLOGY, 2020, 72 : 1010 - 1011
  • [33] Anti-fibrotic potential of a novel long-acting Glucagon/GIP/GLP-1 triple agonist (HM15211) in preclinical models of idiopathic pulmonary fibrosis
    Lee, S.
    Kim, J.
    Lee, J.
    Kim, J.
    Ban, Y. -H.
    Lee, J.
    Bae, S.
    Kim, D.
    Lee, S.
    Choi, I.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S431 - S431
  • [34] Anti-fibrotic Potential of a Novel Long-acting Glucagon/GIP/GLP-1 Triple Agonist (HM15211) in Preclinical Models of Idiopathic Pulmonary Fibrosis
    Kim, J.
    Kim, W.
    Lee, S.
    Lee, J.
    Kim, J.
    Bae, S.
    Kim, D.
    Lee, S.
    Choi, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [35] EFFECTS OF HM15211, A NOVEL LONG-ACTING GLUCAGON/GIP/GLP-1 TRIPLE AGONIST, ON ANTI-INFLAMMATION AND ANTI-FIBROSIS IN TAA-INDUCED MOUSE MODEL OF LIVER INJURY AND FIBROSIS
    Kwon, Hyunjoo
    Kim, Jung Kuk
    Lee, Jong Suk
    Kim, Yohan
    Park, Eun Jin
    Choi, Jaehyuk
    Bae, Sung Min
    Kim, Dae Jin
    Lee, Sang Hyun
    Choi, In Young
    HEPATOLOGY, 2022, 76 : S716 - S717
  • [36] Potent Body Weight Loss and Efficacy in a NASH Animal Model by a Novel Long-Acting GLP-1/Glucagon/GIP Tri-Agonist (HM15211)
    Choi, In Young
    Lee, Jong Suk
    Kim, Jung Kuk
    Park, Young Jin
    Jung, Sungyoub
    Kim, Young Hoon
    Kwon, Se Chang
    DIABETES, 2017, 66 : A304 - A304
  • [37] Direct Anti-Inflammatory and Antifibrotic Effects of a Novel Long-Acting Glucagon/GIP/GLP-1 Triple Agonist, HM15211, in Thioacetamide-Induced Mouse Model of Liver Injury and Fibrosis
    Kim, Jung Kuk
    Lee, Jong Suk
    Kim, Yohan
    Lee, Seon Myeong
    Kwon, Hyunjoo
    Park, Eunjin
    Choi, Jaehyuk
    Bae, Sungmin
    Kim, Daejin
    Lee, Sang Hyun
    Choi, In Young
    DIABETES, 2022, 71
  • [38] Anti-inflammatory and anti-fibrotic effects of a novel long-acting Glucagon/GIP/GLP-1 triple agonist, HM15211, in TAA induced mouse model of liver injury and fibrosis
    Kim, J.
    Lee, J.
    Kim, Y.
    Lee, S.
    Kwon, H.
    Park, E.
    Choi, J.
    Bae, S.
    Kim, D.
    Lee, S.
    Choi, I.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S400 - S401
  • [39] Potent body weight loss, and therapeutic efficacy in a NASH animal model by a novel long-acting GLP-1/Glucagon/GIPtri-agonist (HM15211)
    Choi, I.
    Lee, J.
    Kim, J.
    Park, Y.
    Lee, S.
    Kim, Y.
    Kwon, S. -C.
    DIABETOLOGIA, 2017, 60 : S50 - S50
  • [40] Direct anti-inflammatory and anti-fibrotic effects of a novel long-acting Glucagon/GIP/GLP-1 triple agonist, HM15211, in thioacetamide-induced mouse model of liver injury and fibrosis
    Kim, Jung Kuk
    Lee, Jong Suk
    Kim, Yohan
    Lee, Seonmyeong
    Choi, Jaehyuk
    Kwon, Hyunjoo
    Park, Eun Jin
    Bae, Sung Min
    Kim, Dae Jin
    Lee, Sang Hyun
    Choi, In Young
    JOURNAL OF HEPATOLOGY, 2022, 77 : S469 - S469
12345